Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

v3.22.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows For Operating Activities:    
Net Loss $ (2,028,320) $ (2,218,979)
Adjustments To Reconcile Net Loss To Net Cash Used By Operating Activities:    
Non cash lease expense 21,197 5,239
Employee And Director Equity Based Compensation 570,629 975,024
Stock And Warrants Issued For Services Rendered - Related Party 0  
Amortization Of Deferred R&d Obligations Participation Agreements (136,848) 0
Stock And Warrants Issued For Services Rendered 22,400  
Changes In Assets And Liabilities:    
Warrants Issued For Directors' Fees 0  
Security Deposits (29,058) 0
Employee Option Expense 1,601,909  
Prepaid Expenses (797,179) (196,493)
Amortization Of Lease Liability 16,257  
Accounts Payable 133,966 175,533
Lease Liabilities 185 (2,060)
Gain On Forgiveness Of Debt (121,700)  
Advanced Payments For R&d Obligations - Participation Agreements 0 55,201
Amortization Of Deferred R&d Obligation - Participation Agreements (350,099)  
Accrued Liabilities (328,289) 154,537
Net Cash (used In) Operating Activities (2,861,649) (1,051,998)
Cash Flows From Investing Activities:    
Advanced Payments For Deferred R&d Obligation - Participation Agreements 85,303  
Net Cash From By Investing Activities 0 0
Cash Flow From Financing Activities:    
Proceeds Of Loans Payable, Other 628,600 190,500
Payments Of Loans Payable, Other (69,844) (31,850)
Deferred Offering Expenses 0 (143,377)
Proceeds From Sale Of Common Stock Warrants - Participation Agreements 0 40,799
Proceeds From Loan Payable, Related Party - Net Of Repayments 0  
Proceeds From Sale Of Common Stock - Related Party 0 50,000
Proceeds From Sales Of Common Stock 0 1,040,000
Net Cash Provided By Financing Activities 558,756 1,146,072
Increase (decrease) In Cash (2,302,893) 94,074
Proceeds From Exercise Of Common Stock Warrants 0  
Cash At Beginning Of Period 8,901,875 137,862
Proceeds From Public Sale Of Common Stock And Common Stock Warrants 14,552,740  
Cash At End Of Period 6,598,982 231,935
Proceeds From Exercise Of Public Warrants 1,091,767  
Cash Paid During The Period For:    
Interest 1,213 514
Expenses Related To Public Offering (1,697,830)  
Income Taxes 0 $ 0
Interest $ 3,084